Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.

MLA

Østern, Rune, et al. “Diagnostic Laboratory Testing for Charcot Marie Tooth Disease (CMT): The Spectrum of Gene Defects in Norwegian Patients with CMT and Its Implications for Future Genetic Test Strategies.” BMC Medical Genetics, vol. 14, Sept. 2013, p. 94. EBSCOhost, https://doi.org/10.1186/1471-2350-14-94.

APA

Østern, R., Fagerheim, T., Hjellnes, H., Nygård, B., Mellgren, S. I., & Nilssen, Ø. (2013). Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies. BMC Medical Genetics, 14, 94. https://doi.org/10.1186/1471-2350-14-94

Chicago

Østern, Rune, Toril Fagerheim, Helene Hjellnes, Bjørn Nygård, Svein I Mellgren, and Øivind Nilssen. 2013. “Diagnostic Laboratory Testing for Charcot Marie Tooth Disease (CMT): The Spectrum of Gene Defects in Norwegian Patients with CMT and Its Implications for Future Genetic Test Strategies.” BMC Medical Genetics 14 (September): 94. doi:10.1186/1471-2350-14-94.